0000019617-15-000131.txt : 20150121 0000019617-15-000131.hdr.sgml : 20150121 20150121150155 ACCESSION NUMBER: 0000019617-15-000131 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150121 DATE AS OF CHANGE: 20150121 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syneron Medical Ltd. CENTRAL INDEX KEY: 0001291361 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80182 FILM NUMBER: 15538387 BUSINESS ADDRESS: BUSINESS PHONE: 972-4-909-6200 MAIL ADDRESS: STREET 1: INDUSTRIAL ZONE STREET 2: P.O.B. 550 CITY: YOKNEAM ILLIT STATE: L3 ZIP: 20692 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JPMORGAN CHASE & CO CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 270 PARK AVE STREET 2: 38TH FL CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 270 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: J P MORGAN CHASE & CO DATE OF NAME CHANGE: 20010102 FORMER COMPANY: FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/ DATE OF NAME CHANGE: 19960402 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 SC 13G/A 1 SYNERON_MEDICAL_LTD.HTM

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549


 

SCHEDULE 13G/A

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

( AMENDMENT 3)

 


 

SYNERON MEDICAL LTD.

( NAME OF ISSUER )

 

COMMON STOCK

(Title of Class of Securities)

 

M87245102

(CUSIP Number)

 

DECEMBER 31, 2014

(Date of Event Which Requires Filing of this Statement)

 


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 

X Rule 13d-1 (b)

 

 

Rule 13d-1 (c)

 

 

Rule 13d-1 (d)

 


CUSIP No. M87245102

13G/A

Page 1 of 3 pages


1.

Names of reporting persons

JPMorgan Chase & Co.

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

13-2624428

 


2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)

 

 

(b)


3.

SEC USE ONLY


4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 


NUMBER OF

5.

SOLE VOTING POWER

1,743,534

SHARES

 

 

 

BENEFICIALLY

6.

SHARED VOTING POWER

0

OWNED BY

 

 

 

EACH

7.

SOLE DISPOSITIVE POWER

2,076,653

REPORTING

 

 

 

PERSON WITH

8.

SHARED DISPOSITIVE POWER

0

 


9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  2,076,653


10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

 

 

CERTAIN SHARES

 

 


11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.6%

 


12.

TYPE OF REPORTING PERSON*

HC

 


Item 1(a).

Name of Issuer:

 

SYNERON MEDICAL LTD.

Item 1(b).

Address of Issuer's Principal Executive Offices:

 

Industrial Zone

Yokneam Illit, 20692

Tavor Building

P.O.B. 550

Israel

 

 

Item 2(a).

Name of Person Filing:

 

JPMorgan Chase & Co.

Item 2(b).

Address of Principal Business Office or, if None, Residence:

 

270 PARK AVE

 

NEW YORK, NY 10017

Item 2(c).

Citizenship

 

Delaware

Item 2(d).

Title of Class of Securities:

 

COMMON STOCK

 

Unless otherwise noted, security being reported is common stock

Item 2(e).

CUSIP Number:

M87245102

Item 3

If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)

 

Or (c), Check Whether the Person Filing is a :

 

(a)

Broker or dealer registered under Section 15 of the Exchange Act;

 

(b)

Bank as defined in Section 3(a)(6) of the Exchange Act;

 

(c)

Insurance company as defined in Section 3(a)(19) of the

 

 

 

Exchange Act;

 

(d)

Investment company registered under Section 8 of the Investment

 

 

 

Company Act;

 

(e)

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 

(f)

An employee benefit plan or endowment fund in accordance with

 

 

 

Rule 13d-1(b)(1)(ii)(F);

 

(g)

X

A parent holding company or control person in accordance with

 

 

 

Rule 13d-1(b)(1)(ii)(G);

 

(h)

A savings association as defined in Section 3(b) of the Federal

 

 

 

Deposit Insurance Act;

 

(i)

A church plan that is excluded from the definition of an

 

 

 

Investment company under Section 3(c)(14) of the Investment

 

 

 

Company act;

 

(j)

Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

If this statement is filed pursuant to Rule 13d-1(b), check this box.

X

 


Page 2 of 3 pages

Item 4.

Ownership

 

Provide the following information regarding the aggregate number and

 

Percentage of the class of securities of issuer identified in Item 1.

 

(a)

Amount beneficially owned: 2,076,653

 

 

Including 0 shares where there is a Right to Acquire.

 

(b)

Percent of class: 5.6%

 

(c)

Number of shares as to which such person has:

 

 

(i)

Sole power to vote or to direct the vote:

1,743,534 

 

 

(ii)

Shared power to vote or to direct the vote:

0

 

 

(iii)

Sole power to dispose or to direct the disposition of:

2,076,653

 

 

(iv)

Shared power to dispose or to direct the disposition of:

0

 

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date

hereof the reporting person has ceased to be the beneficial owner of more

than five percent of the class of securities, check the following. ( )

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

JPMorgan Chase & Co. is the beneficial owner of 2,076,653 shares of the

issuer's common stock on behalf of other persons known to have one or more of

the following:

 

the right to receive dividends for such securities;

 

the power to direct the receipt of dividends from such securities;

 

the right to receive the proceeds from the sale of such securities;

 

the right to direct the receipt of proceeds from the sale of such securities;

No such person is known to have an interest in more than 5% of the class of

securities reported herein unless such person is identified below.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the

 

Security being reported on by the Parent Holding Company.

This notice is filed on behalf of JPMorgan Chase & Co. and its wholly owned

Subsidiary (ies),

JPMorgan Chase Bank, National Association

J.P. Morgan Investment Management Inc.

JPMorgan Asset Management (Canada) Inc.

JPMorgan Asset Management (UK) Limited

 

Item 8.

Identification and Classification of Members of the Group.

 

Not Applicable

 

Item 9.

Notice of Dissolution of Group.

 

Not Applicable

 

Item 10.

Certifications

 

By signing below I certify that, to the best of my knowledge and belief,

the securities referred to above were acquired and are held in the ordinary

course of business and were not acquired and are not held for the purpose

of or with the effect of changing or influencing the control of the issuer of the

securities and were not acquired and are not held in connection with or as a

participant in any transaction having that purpose or effect.

 

 


Page 3 of 3 pages 

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the

information set forth in this statement is true, complete and correct.

Dated: JANUARY 21, 2015

JPMorgan Chase & Co.

 

By: /s/ Margaret R. Rubin

 

--------------------------------------

 

Margaret R. Rubin

 

Compliance

 

 

 

 

The original statement shall be signed by each person on whose behalf the statement

is filed or his authorized representative. If the statement is signed on behalf of

a person by his authorized representative (other than an executive officer or general

partner of the filing person), evidence of the representative's authority to sign on

behalf of such person shall be filed with the statement, provided, however, that a

power of attorney for this purpose which is already on file with the commission may

be incorporated by reference. The name and any title of each person who signs the

the statement shall be typed or printed beneath his signature.